Skip to Main Content
Centers for Disease Control and Prevention link     Centers for Disease Control and Prevention & Smallpox Centers for Disease Control and Prevention link CDC Smallpox Home
Smallpox Vaccination and Adverse Events Training Module - Reactions Links & Site Map Adverse Reactions link Normal Reactions link All Reactions link Site Map link
Side Navigation Menu & Copyright 2002 CDC/HHS Home Page link Smallpox link About the Vaccine link Contraindications link Vaccination Method link Preventing Contact Transmission link Vaccinia Immune Globulin link; Laboratory Testing link Continuing Education link Contact link

About the Vaccine: General

In-depth Vaccine Information link Immunity Against Smallpox link Emergency Vaccination link References link General Info link About the Vaccine Menu



Smallpox vaccine is made from live vaccinia virus and does not contain variola virus, the virus that causes smallpox. Vaccinia virus is a member of the orthopox virus family, which includes smallpox (variola), cowpox, monkeypox, gerbilpox, camelpox and others. When inoculated in the superficial layers of the skin, the virus grows and induces an immune reaction that serves to protect against smallpox. 

A successful vaccination is often referred to as a “take”. More information about takes, including pictures, can be obtained by clicking on the “Normal Reactions” link above. 

Two vaccines will be used in the coming years:

Vial of smallpox vaccine
Calf-Lymph Vaccine

Dryvax, a stored calf-lymph vaccine manufactured in the 1970’s by Wyeth Laboratories, is freeze dried (lyophilized) and must be reconstituted with a diluent before use.

The vaccine currently licensed will be used in 2003 to fulfill the recommendations of the national Advisory Committee on Immunization Practice (ACIP) for immunization of smallpox public health and healthcare response teams.

Dryvax is also being used ito immunize laboratory workers who require vaccination to safely conduct research activities involving vaccinia or other orthopoxviruses.

Note: Dryvax contains antibiotics and preservatives. 

Appropriate history of allergies to any of the following should be obtained and may negate vaccine administration when smallpox is not present:

•  Polymyxin B sulfate
•  Streptomycin sulfate
•  Chlortetracycline hydrochloride
•  Neomycin sulfate

If smallpox is present and the risk of contact great, the vaccine should be administered with subsequent use of an appropriate antihistamine or other medication.

For more information on both types of vaccines, please visit the In-depth Vaccine Information page.

 

 

Tissue Culture Cell Vaccine

As of October 2002, tissue culture cell vaccines are in preparation by Acambis-Baxter Laboratories.

Two cell lines were selected for propagation of vaccinia virus:

•  Vero monkey kidney cells
•  Human fibroblast cell line (MRC5)

Several lots of both vaccines have been prepared and are undergoing testing. It is anticipated that one of these vaccines will supplant calf-lymph vaccine if a more extensive vaccination program is implemented.

Accidental Administration link Inadvertent Inoculation link Bacterial Infection link Congenital Vaccinia link Eczema Vaccinatum link Encephalitis link Erythema Multiforme link Generalized Vaccinia link Normal Primary link Normal Variants link Progressive Vaccinia link Vaccinia Keratitis link Revaccination link All Reactions links